Rough French maritime pine bark and a glass dish of rust-red pycnogenol powder on cream, with a headline on studied doses.

Pycnogenol: What the Doses Were and What the Evidence Actually Shows

Pycnogenol arrives with a big reputation and a surprisingly thin paper trail. It has a patent, a trademark, decades of published trials, and a set of independent reviews that still grade the evidence as very low certainty. Both things are true at once. This guide shows what pycnogenol is, which dose the human trials used for which outcome, and where the honest limits sit.

What Is Pycnogenol?

Pycnogenol is a patented, standardized extract made from the bark of the French maritime pine, Pinus pinaster Aiton subspecies atlantica. The trees grow along the coast of southwest France, and the raw material comes from a known, controlled source.

The extract is concentrated for a family of polyphenol antioxidants called procyanidins. Commercial Pycnogenol is standardized to 65 to 75 percent procyanidins, and it holds a United States Pharmacopeia monograph under the name "Pine extract." That monograph matters, because it gives manufacturers a defined identity test for the raw material.

The trademark is why you see Pycnogenol with a capital P on a label. It is a brand name for one specific ingredient, licensed to a limited number of makers. It is not a general synonym for pine bark.

That distinction becomes the whole buying question later, so hold onto it.

French maritime pine bark beside a glass dish of rust-red pycnogenol powder on a cream surface — Pycnogenol is a standardized extract of French maritime pine bark, not a generic pine bark powder.

How Pycnogenol Works in the Body

Pycnogenol is studied for three overlapping activities, all described here in ordinary structure and function language.

Antioxidant activity. The procyanidins act as free radical scavengers. In one small human study, plasma taken after volunteers ingested the extract inhibited both COX-1 and COX-2 enzymes (PMID 16330178). That is a lab measurement, not a health outcome, but it is one of the few pieces of human data on how the extract behaves after swallowing.

Support for endothelial function. The endothelium is the lining of your blood vessels, and it helps regulate how they widen and narrow. Trials measure it with flow-mediated dilatation, a standard gauge of how well that lining works.

Support for the extracellular matrix. The matrix is the scaffolding between cells, and the structural part of skin, veins, and joint cartilage. Pycnogenol is studied for supporting the collagen and elastin side of it.

For the wider antioxidant category, our Detox and Methylation resource page covers how Agape Nutrition approaches it. The key word is studied: the human outcome data is mixed, and the next section shows how.

The Dose-by-Outcome Evidence Table

This is the part almost no consumer page publishes. Most give a single range like "50 to 200 mg," which tells you nothing about which dose was tested for which outcome.

The trials used specific doses. Here they are, with what each study measured and the PubMed ID so you can look it up.

Horizontal bar chart of pycnogenol doses by outcome: 300 mg leg swelling, 200 mg joint comfort, down to 60 mg — Doses shown are daily doses drawn from the pycnogenol trials. Most of those trials were small and short.

Outcome studied	Dose studied	Duration	What the trial measured	PMID
Leg heaviness and swelling in chronic venous insufficiency (CVI)	100 mg, 3 times daily	2 months	Significant reduction in subcutaneous edema and in leg heaviness and pain; no effect on venous blood flow was observed	10844161
Leg heaviness and swelling in CVI (second trial)	100 mg, 2 to 3 times daily	2 months	Same direction of findings in a separate 40-patient study	11081989
CVI, versus a diosmin plus hesperidin product	150 or 300 mg daily vs 1,000 mg daily of the comparator	8 weeks	Improvement reached significance at 4 weeks in most patients; the authors report superiority on their measured parameters	16708123
CVI, with and without compression stockings	150 mg daily alone vs stockings alone vs both	8 weeks	The extract alone outperformed compression alone on all parameters (p<0.05); the combination performed best	20579863
Endothelial function in coronary artery disease	200 mg daily	8 weeks	Flow-mediated dilatation rose from 5.3 to 7.0 (p<0.0001) while placebo showed no change; an oxidative stress marker fell	22240497
Blood pressure alongside a calcium channel blocker	100 mg daily	12 weeks	Allowed a significant reduction in medication dose; endothelin-1 fell versus placebo; the nitric oxide rise was not significant	14659974
Blood pressure (pooled meta-analysis, 9 trials, 549 participants)	150 to 200 mg daily	Varied; larger effect beyond 12 weeks	Pooled systolic pressure 3.22 mmHg lower, diastolic 3.11 mmHg lower, but the effect was not seen in well-designed trials	30087862
Menopause-related symptoms	30 mg, twice daily	3 months	Significant improvement in vasomotor and sleep symptoms versus placebo; total symptom index fell 56% versus 39% on placebo	23447917
Skin hydration and elasticity in outdoor workers	50 mg, twice daily	12 weeks	Prevented the seasonal drop in skin hydration and the rise in water loss, prevented skin darkening, improved elasticity and elastic recovery	33789311
Osteoarthritis pain (meta-analysis of 69 supplement studies)	Various across included trials	Short term vs medium and long term	Large short-term pain effect (effect size above 0.80) but very low quality of evidence; no supplement showed a clinically important effect at long term	29018060
Muscle cramps	200 mg daily	4 weeks	Cramps per week fell from 4.8 to 1.3 in healthy subjects and 8.6 to 2.4 in athletes, still present at week 5	16703193
ADHD symptoms in children (two small pediatric RCTs)	Not stated in the abstract	Short term	Reduced oxidative DNA damage and changes in catecholamine measures	17015282, 18019397
Tinnitus (pilot study)	100 to 150 mg daily	Pilot	Exploratory measurement of cochlear blood flow	20657537

A few things jump out once you see it in one place.

The doses are all over the map. 30 mg twice daily for menopause symptoms, 100 mg daily for blood pressure, 100 mg two to three times daily for vein symptoms, 200 mg daily for endothelial function. There is no single right dose, only a dose that matches the outcome that was studied.
Most trials were short and small. Two months, eight weeks, twelve weeks, and often only 20 to 60 participants.
One row is not like the others. The comparison against a diosmin plus hesperidin product was not blinded, had no placebo arm, and came from the same research group behind much of the positive literature. Its "superiority" claim is the study's own conclusion.

The Honest Evidence Grade: Two Cochrane Reviews

Cochrane reviews sit at the top of the evidence hierarchy. They pool every eligible trial, assess the risk of bias in each, and grade the certainty of the evidence. Two have now looked at pine bark extract.

The 2012 review pooled 15 trials and 791 participants across seven conditions. Its conclusion was blunt: current evidence is insufficient to support the use of Pycnogenol for the treatment of any chronic disorder (PMID 22336841).

The 2020 update widened the scope to pine bark extracts generally. It pooled 27 randomized trials and 1,641 participants across ten conditions. Risk of bias was low in 4 trials, high in 1, and unclear in 22. Every outcome was graded very low certainty. The reviewers concluded that no definitive conclusions about efficacy or safety are possible (PMID 32990945).

So why does the evidence land there, when dozens of published trials look positive?

Tiny samples. Small studies are more likely to show a large effect by chance, and less likely to be confirmed on repeat.
Single centres. Most ran at one site rather than across independent locations.
Largely one research group. A substantial share of the positive literature comes from a few authors connected to the ingredient. That is not proof of anything improper, but independent replication is what turns a promising signal into an established one.
Short durations and poor reporting. Weeks to months, rarely longer, often with missing detail on randomization, blinding, and dropouts.

None of that means pycnogenol does nothing. It means the published studies cannot prove what they claim.

For balance, a manufacturer-affiliated review published in 2024 counts 39 randomized, double-blind, placebo-controlled trials covering 2,009 subjects, with benefits reported across cardiovascular, vein, cognition, joint, skin, eye, women's health, respiratory, oral, and sports outcomes (PMID 38757130). It is worth knowing the number exists, and worth knowing it was written with interests tied to the ingredient. Weigh it as an industry overview, not an independent verdict.

Blood Pressure: A Small Pooled Effect With a Real Caveat

The most quoted pycnogenol number is the blood pressure meta-analysis, pooling 9 trials and 549 participants at 150 to 200 mg daily (PMID 30087862). The pooled results:

Systolic blood pressure about 3.22 mmHg lower
Diastolic blood pressure about 3.11 mmHg lower

The effect was larger in people who already had elevated blood pressure, and in trials running longer than 12 weeks.

Here is the caveat most supplement pages leave out: the effect was not observed in well-designed trials. That is the most important line in this section. When the analysis was restricted to the stronger studies, the difference did not hold up.

A pooled average can be statistically significant while the underlying studies remain too weak to trust. That is the situation here. If you take blood pressure medication, do not adjust anything based on this article. Talk to your prescriber. Our Heart and Circulation resource page covers the wider category if you are browsing that aisle.

Joint Pain: A Large Short-Term Signal, Graded Very Low

The other headline outcome is osteoarthritis. The key source is a systematic review and meta-analysis of 69 supplement studies (PMID 29018060).

Pycnogenol was one of seven supplements showing a large short-term pain reduction, defined as an effect size above 0.80. That is a big number. Then come the two qualifications, which matter as much as the headline:

The overall quality of evidence was very low. The large effect rides on studies that do not meet a high methodological bar.
No supplement showed a clinically important effect at long term. At medium term only two did, green-lipped mussel and undenatured type II collagen, and neither is pycnogenol. For this ingredient the short-term relief did not carry forward.

The fair read: a possible real short-term signal, not backed by strong or durable evidence. Agape Nutrition's Bone, Joint and Pain resource page lays out the broader options in that category, which is a better starting point than a single ingredient if joint comfort is the goal.

Why Form Matters: Absorption and Bioavailability

Almost no consumer page explains what happens after you swallow it. That gap matters, because it explains why form and standardization change the experience.

Pine bark extract is a mixture, not one molecule. Its constituents behave differently in the gut.

What absorbs intact. The low molecular weight constituents cross into the bloodstream from the small intestine. Those include catechin, caffeic acid, ferulic acid, and taxifolin (PMIDs 16887024, 38757126).

What needs gut bacteria. The larger procyanidin oligomers and polymers do not absorb intact. They travel to the colon, where gut bacteria break them into smaller metabolites that can be absorbed. One of the main ones is 5-(3',4'-dihydroxyphenyl)-gamma-valerolactone. In other words, a large share of the active compounds depend on your gut microbiome to become bioavailable at all. That varies from person to person, and it is one reason the same dose can land differently.

Where they go. Constituents have been detected in blood cells, in synovial fluid inside joints, and in saliva (PMID 38757126), and they are excreted through the kidneys (PMIDs 16887024, 10889455).

Diagram of how pycnogenol is absorbed, from pine bark capsule to gut bacteria to bloodstream and joint fluid — Larger procyanidins depend on gut bacteria to be broken into absorbable metabolites.

The practical takeaways:

Standardization is not marketing decoration. Without a defined procyanidin content, you do not know what you are absorbing or how much.
A branded, standardized extract removes one variable. You cannot control your gut bacteria, but you can control whether the raw material is the same every batch.
This same principle drives our other form-matters articles. The resveratrol supplement guide covers another polyphenol with the identical bioavailability problem, and the quercetin supplement guide shows how chemical form changes what you absorb.

How to Choose a Pycnogenol Supplement

Three products can all say "pine bark" on the front and mean different things.

Branded Pycnogenol vs generic pine bark extract. Branded Pycnogenol is the patented extract from the French maritime pine, standardized to 65 to 75 percent procyanidins, covered by a USP monograph. Generic pine bark extract may come from another pine species, another part of the tree, or a blend, without the same standardization guarantee. The label should say "Pycnogenol" specifically if that is what you are paying for.

Pine bark extract vs grape seed extract. Both are procyanidin-rich and both come up in vein and antioxidant conversations. They are different raw materials with different procyanidin profiles, and grape seed extract is typically the less expensive. Our vein support supplements guide discusses how these polyphenol ingredients fit together.

Three specimen jars comparing branded pycnogenol, generic pine bark extract and grape seed procyanidins — These are different raw materials, not interchangeable doses. Standardization is what makes a dose repeatable.

What to look for:

The word "Pycnogenol" with standardization stated, or a clear procyanidin percentage for a generic extract
The dose per capsule, so you can match it to a dose that was actually studied
Third-party testing or a USP verification mark, confirming identity and purity
Capsules over loose powder. Capsules give a consistent measured dose, and pine bark powder is bitter and hard to measure by scoop

Agape Nutrition stocks three branded options: Pycnogenol 100 mg from Pure Encapsulations, Pycnogenol-50 from DaVinci Laboratories, and Pycnogenol 100 VegiCaps from Allergy Research Group. They differ mainly in strength per capsule. If supplement facts panels are new to you, our guide to reading a supplement label breaks down each line.

A word on expectations. Given the evidence grade above, the reasonable posture is cautious curiosity, not certainty. Buy from a maker who standardizes and tests, take the dose matching the outcome you care about, and judge over a defined period.

Safety, Side Effects, and Interactions

Pycnogenol is generally well tolerated in the trials run so far. Reported side effects tend to be mild and uncommon, and studies that tracked safety did not flag serious concerns. That said, the 2020 Cochrane review noted safety data were too limited for firm conclusions, so "well tolerated in short trials" is accurate, not "proven safe."

The interaction to take seriously is with blood thinners. Because the extract is studied for effects on platelets and circulation, there is a commonly cited concern about combining it with antiplatelet or anticoagulant medication. If you take warfarin, apixaban, rivaroxaban, clopidogrel, or aspirin for a cardiac reason, talk to your prescriber first.

Stop before surgery. For the same reason, standard practice is to discontinue at least two weeks before a scheduled procedure. Confirm the timing with your surgical team.

Pregnancy and breastfeeding. There is not enough reliable data to call pycnogenol safe in that window. The cautious default is to avoid it unless a clinician who knows your situation advises otherwise.

Two more notes:

If you take blood pressure or diabetes medication, do not change your dose based on anything here, including the blood pressure meta-analysis. That is a conversation for your prescriber.
If you take multiple medications or manage a chronic condition, run the list past a pharmacist. This is general education, not personal medical advice.

All three options below are the branded, standardized extract, so the real choice comes down to strength per capsule and cost per bottle. Match the capsule strength to the dose the trials used for the outcome you care about, and judge it over a defined window rather than a single dose.

Pure Encapsulations Pycnogenol 100 mg

One capsule delivers 100 mg, the strength several vein and blood pressure trials used, in a 30-capsule or 60-capsule bottle.

$85.40 for 30 capsules

DaVinci Labs Pycnogenol-50

One capsule delivers 50 mg, so a 30-capsule or 60-capsule bottle lets you build the 50 mg twice daily dose the skin trial used.

$48.56 for 30 capsules

Allergy Research Group Pycnogenol 100

One capsule delivers 100 mg, the strength the vein and blood pressure trials used, in a single 30-count bottle of vegetarian capsules.

$64.29 for 30 VegiCaps

References

Schäfer A et al. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomedicine & Pharmacotherapy. 2006. https://pubmed.ncbi.nlm.nih.gov/16330178/
Arcangeli P. Pycnogenol in chronic venous insufficiency. Fitoterapia. 2000. https://pubmed.ncbi.nlm.nih.gov/10844161/
Petrassi C, Mastromarino A, Spartera C. PYCNOGENOL in chronic venous insufficiency. Phytomedicine. 2000. https://pubmed.ncbi.nlm.nih.gov/11081989/
Cesarone MR et al. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study. Clinical and Applied Thrombosis/Hemostasis. 2006. https://pubmed.ncbi.nlm.nih.gov/16708123/
Cesarone MR et al. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study. Phytomedicine. 2010. https://pubmed.ncbi.nlm.nih.gov/20579863/
Enseleit F et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. European Heart Journal. 2012. https://pubmed.ncbi.nlm.nih.gov/22240497/
Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald P. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sciences. 2004. https://pubmed.ncbi.nlm.nih.gov/14659974/
Zhang Z, Tong X, Wei YL, Zhao L, Xu JY, Qin LQ. Effect of Pycnogenol Supplementation on Blood Pressure: A Systematic Review and Meta-analysis. Iranian Journal of Public Health. 2018. https://pubmed.ncbi.nlm.nih.gov/30087862/
Kohama T, Negami M. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial. The Journal of Reproductive Medicine. 2013. https://pubmed.ncbi.nlm.nih.gov/23447917/
Zhao H, Wu J, Wang N, Grether-Beck S, Krutmann J, Wei L. Oral Pycnogenol® Intake Benefits the Skin in Urban Chinese Outdoor Workers: A Randomized, Placebo-Controlled, Double-Blind, and Crossover Intervention Study. Skin Pharmacology and Physiology. 2021. https://pubmed.ncbi.nlm.nih.gov/33789311/
Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. British Journal of Sports Medicine. 2018. https://pubmed.ncbi.nlm.nih.gov/29018060/
Vinciguerra G et al. Cramps and muscular pain: prevention with pycnogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy. Angiology. 2006. https://pubmed.ncbi.nlm.nih.gov/16703193/
Chovanová Z et al. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radical Research. 2006. https://pubmed.ncbi.nlm.nih.gov/17015282/
Dvoráková M et al. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Nutritional Neuroscience. 2007. https://pubmed.ncbi.nlm.nih.gov/18019397/
Grossi MG et al. Improvement in cochlear flow with Pycnogenol® in patients with tinnitus: a pilot evaluation. Panminerva Medica. 2010. https://pubmed.ncbi.nlm.nih.gov/20657537/
Schoonees A, Visser J, Musekiwa A, Volmink J. Pycnogenol(®) for the treatment of chronic disorders. Cochrane Database of Systematic Reviews. 2012. https://pubmed.ncbi.nlm.nih.gov/22336841/
Robertson NU, Schoonees A, Brand A, Visser J. Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database of Systematic Reviews. 2020. https://pubmed.ncbi.nlm.nih.gov/32990945/
Weichmann F, Rohdewald P. Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies. Frontiers in Nutrition. 2024. https://pubmed.ncbi.nlm.nih.gov/38757130/
Grimm T et al. Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers. BMC Clinical Pharmacology. 2006. https://pubmed.ncbi.nlm.nih.gov/16887024/
Bayer J, Högger P. Review of the pharmacokinetics of French maritime pine bark extract (Pycnogenol®) in humans. Frontiers in Nutrition. 2024. https://pubmed.ncbi.nlm.nih.gov/38757126/
Virgili F et al. Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract. Free Radical Biology & Medicine. 2000. https://pubmed.ncbi.nlm.nih.gov/10889455/

Frequently Asked Questions

What is pycnogenol good for?

It has been studied for leg heaviness and swelling in chronic venous insufficiency, endothelial function, blood pressure support, skin hydration and elasticity, menopause-related symptoms, muscle cramps, and short-term joint pain. Independent reviewers rate the certainty of that evidence as very low, so it is studied for these outcomes, which is different from being proven for them.

What is the standard pycnogenol dose?

There is no single standard. Trials used 30 mg twice daily for menopause symptoms, 50 mg twice daily for skin, 100 mg daily for blood pressure, 100 mg two to three times daily for vein symptoms, and 200 mg daily for endothelial function and muscle cramps. Match the dose to the outcome you care about.

Is pycnogenol the same as pine bark extract?

No. Pycnogenol is a specific patented extract from the French maritime pine, standardized to 65 to 75 percent procyanidins. Generic pine bark extract may come from other pine species or blends without the same standardization.

Is pycnogenol the same as grape seed extract?

No. They are different raw materials, though both are rich in procyanidins. Grape seed extract is typically the less expensive of the two.

How long does pycnogenol take to work?

In the published trials, measured changes appeared over 4 to 12 weeks depending on the outcome: 8 weeks to 2 months for the vein trials, 12 weeks for skin, and 4 weeks for muscle cramps. Give it a defined window rather than expecting a same-day effect.

Can I take pycnogenol with blood thinners?

Talk to your prescriber first. Because it is studied for effects on platelets and circulation, there is a commonly cited interaction concern with antiplatelet and anticoagulant medication. The same caution applies before surgery, where the usual advice is to stop at least two weeks ahead.

Why do some sources call pycnogenol proven and others say the evidence is insufficient?

Because there are two bodies of literature. Many individual trials report positive results, and many of those come from a small group of researchers connected to the ingredient. Independent reviewers who pool every trial and grade how well it was run, including the 2020 Cochrane review, find the certainty across each outcome to be very low. Both statements describe the same literature.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Older Post

Back to Agape Nutrition Health Blog

Newer Post

Your Order